Replagal (agalsidase alfa)

pCPA File Number: 20716
Negotiation Status:
Concluded with an LOI
Indication(s):
Fabry Disease
Sponsor/Manufacturer:
Shire Pharma Canada ULC
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: